Expression of prostate specific antigen (PSA) is negatively regulated by p53 (original) (raw)

P53 Nuclear Accumulation as an Early Indicator of Lethal Prostate Cancer

John Grygiel

British Journal of Cancer, 2019

View PDFchevron_right

Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer

Dennis Görlich

PLOS ONE, 2017

View PDFchevron_right

PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis

Monica Celli

Scientific Reports, 2018

View PDFchevron_right

EXPRESSION OF p53 IN HUMAN BREAST CANCER

Veaceslav Fulga

Biological Markers in Fundamental and Clinical Medicine (collection of abstracts), 2017

View PDFchevron_right

Study of serum prostate specific antigen levels in patients with prostate lesions

DrashtI Shukla

International Journal of Clinical and Diagnostic Pathology, 2021

View PDFchevron_right

Molecular alterations associated with prostate cancer

adalberto sanchez gomez

Central European Journal of Urology, 2018

View PDFchevron_right

BRCA1 and p53 regulate critical prostate cancer pathways

Cristian Moiola

Prostate Cancer and Prostatic Diseases, 2013

View PDFchevron_right

Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen

Bernard Candas

Urology, 1996

View PDFchevron_right

P53: A Molecular Marker for the Detection of Cancer

Nikolina Vlatkovic

Expert Opinion on Medical Diagnostics, 2008

View PDFchevron_right

Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management

Lukman Hakim

Cancer, 1994

View PDFchevron_right

Molecular genetics of prostate cancer

adnan albadran

Annals of Medicine, 2001

View PDFchevron_right

Molecular pathology of prostate cancer

Angelo Marzo

Journal of Clinical Pathology, 2005

View PDFchevron_right

Wagging the long tail of drivers of prostate cancer

Jeffrey Townsend

PLOS Genetics, 2019

View PDFchevron_right

Focus on prostate cancer

Angelo Marzo

Cancer Cell, 2002

View PDFchevron_right

Prostate Cancer, Version 2.2014

Mack Roach

Journal of the National Comprehensive Cancer Network, 2014

View PDFchevron_right

The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention

Angelo Marzo

Urology, 2001

View PDFchevron_right

Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

Scott Lucia

The New England Journal of Medicine, 2004

View PDFchevron_right

Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 Ng/Ml or Lower

Scott Lucia

The Journal of Urology, 2006

View PDFchevron_right

Editorial: Challenges in the prevention of prostate cancer

Andrea Venerando

Frontiers in Oncology, 2023

View PDFchevron_right

P53 in Breast Cancer: Mutation and Countermeasures

Sumit Kumar

Frontiers in Bioscience, 2007

View PDFchevron_right

The Performance of Prostate Specific Antigen for Predicting Prostate Cancer is Maintained After a Prior Negative Prostate Biopsy

Scott Lucia

Journal of Urology, 2008

View PDFchevron_right

Correlation of serum prostate-specific antigen level in various prostate pathology in elderly men

Dr.varsha Khant

International Journal of Medical Science and Public Health, 2017

View PDFchevron_right

Comparing Prostate Specific Antigen Triggers for Intervention in Men With Stable Prostate Cancer on Active Surveillance

Alexandre Mamedov

Journal of Urology, 2010

View PDFchevron_right

Editorial: Molecular drivers of prostate cancer pathogenesis and therapy resistance

Shagun Misra

Frontiers in Cell and Developmental Biology

View PDFchevron_right

Inflammation in prostate carcinogenesis

Angelo Marzo

Nature Reviews Cancer, 2007

View PDFchevron_right

Prostate cancer immunology - an update for Urologists

Damien Bolton

BJU International, 2011

View PDFchevron_right

Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant

Roberto Orozco

1998

View PDFchevron_right

P53-FAMILY Proteins and Their Regulators: Hubs and Spokes in Tumor Suppression

Andrea Lunardi

Cell Death & Differentiation, 2010

View PDFchevron_right

Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels

Federico Licastro

View PDFchevron_right

Complex analysis of the p53 tumor suppressor in lung carcinoma

Jana Smardova

Oncology Reports, 2015

View PDFchevron_right

Five Genetic Variants Associated with Prostate Cancer

Wayne Hall

New England Journal of Medicine, 2008

View PDFchevron_right

p53 Gene Replacement for Cancer&Interactions with DNA Damaging Agents

Susan Grammer

Acta Oncologica, 2001

View PDFchevron_right

Quantitation of Prostate-specific Antigen in Serum by a Sensitive Enzyme Immunoassay1

Luis Valenzuela

View PDFchevron_right

Supplementary Table 2 from Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression

Dan Longo

2023

View PDFchevron_right

Cytochrome p4501A1 gene variants as susceptibility marker for prostate cancer

Sunil Shroff

Cancer Biomarkers, 2005

View PDFchevron_right